If bleeding persists or worsens, it is crucial to seek medical attention
Lifestyle Factors Habits that may support results alongside the protocol
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut
On the other hand, the orexigenic signaling via orexigenic peptides (MCH and orexin A and B neuropeptides) results in increased food intake and decreased energy expenditure
By engaging three key receptors involved in energy balance, insulin release, and lipid metabolism, retatrutide delivers a more comprehensive metabolic effect
B12 binds to proteins in your food and eventually goes to your small intestine, where it gets absorbed
